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1. Summary 
The isolated perfused heart model developed by Langendorff allows the monitoring 
of a broad spectrum of functional, biochemical, morphological and pathological 
indices in a denervated heart under controlled microenvironmental conditions. Main 
limitations of this method include the lack of mechanical loading of the heart muscle 
and poor oxygen supply due to the low oxygen carrying capacity of perfusion fluids 
without red blood cells. As a result rodent hearts perfused via aorta with the Krebs-
Henseleit buffer are usually artificially paced. 
Herein I introduced a novel hollow fibre mini-oxygenator into the Langendorff 
perfusion circuit allowing to reduce its filling volume from 100 ml to 5 ml and less. 
Due to this technical improvement 5-10 ml of blood obtained from the donor rat used 
for heart harvesting are sufficient to fill the system and the isolated heart can 
therefore be perfused with autologous blood. 
This study was focused on the characterization of a new experimental model and the 
comparison of functional and biochemical parameters obtained for the autologous 
blood perfused heart with those measured in vivo. Potential limitations of this method 
were specifically addressed. 
Furthermore, we performed a study in which the new system was used to investigate 
local responses of the isolated heart to hypoxia and ischemia. We assessed changes 
in glucose utilization as well as the associated changes in the tissue redox state and 
ion balance. The obtained data revealed inter-ventricular heterogeneity in responses 
of the rat heart to hypoxia that are most likely linked to the heterogeneity in the 
functional requirements. 
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2. Zusammenfassung 
Das von Langendorff entwickelte, isolierte, perfundierte Herzmodell ermöglicht die 
Beobachtung eines breiten Spektrums funktioneller, biochemischer, morphologischer 
und pathologischer Parameter im denervierten Herzen unter kontrollierten 
Mikroumgebungsbedingungen. Die wichtigsten Beschränkungen dieses Verfahrens 
sind die fehlende mechanische Belastung des Herzmuskels und der mangelnde 
Sauerstofftransport aufgrund der geringen Sauerstoffbindungskapazität der 
erythrozytenfreien Perfusionsflüssigkeiten. Deshalb werden Nagetierherzen, die über 
die Aorta mit dem Krebs-Henseleit Puffer perfundiert werden, in der Regel per 
externem Schrittmacher stimuliert. 
In dieser Arbeit integriere ich einen neuartigen Hohlfaser-Mini-Oxygenator in den 
Langendorff-Perfusionskreislauf und verringere so die benötigte Füllmenge von 
100 ml auf 5 ml oder weniger. Dank dieser technischen Verbesserung genügen 5–
10 ml Blut von der Spenderratte, von der auch das Herz stammt, um das System zu 
füllen. Das isolierte Herz kann also mit Eigenblut perfundiert werden. 
Im Mittelpunkt dieser Studie stehen die Charakterisierung eines neuen 
experimentellen Modells und der Vergleich funktioneller und biochemischer 
Parameter des mit Eigenblut perfundierten Herzens mit den Werten in vivo. Auf 
potenzielle Beschränkungen der Methode wird spezifisch eingegangen. 
Darüber hinaus wurde das neue System in einer Studie eingesetzt, in der lokale 
Reaktionen des isolierten Herzens auf Hypoxie untersucht wurden. Gemessen 
wurden Veränderungen des Glukoseverbrauchs sowie die damit verbundenen 
Veränderungen im Redoxzustand und im Ionengleichgewicht des Gewebes. Die 
gesammelten Daten zeigten, dass die interventrikuläre Heterogenität in der Reaktion 
des Rattenherzens auf Hypoxie mit höchster Wahrscheinlichkeit auf die 
Heterogenität der funktionalen Anforderungen zurückzuführen ist. 
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3. Motivation and structure of the thesis work 
The present study aimed to characterize isolated rat heart responses to acute global 
hypoxia and to compare the observed findings with those obtained for the heart of 
animals exposed to systemic hypoxia in vivo. Moreover, we planned to assess 
possible interventricular variation in hypoxic responses in rat hearts.  
The comparison of the data obtained ex vivo and in vivo allowed us to study the 
acute effects of hypoxic stress in the rat heart in the presence and absence of 
sympathetic and vagal stimulation, assess the possible impact of loading on the 
observed hypoxic responses, and the presence of humoral factors released 
systemically in response to hypoxic exposure.  
This PhD thesis is structured as follows. In an introduction, a brief overview of the 
methods used in cardiovascular research is given, explaining the motivation for the 
development of a new experimental and technical approach which allows avoidance 
of some artifacts related to the pre-existing experimental settings. After the 
introductions follows the body of the thesis which describes the validation of the new 
experimental model and presents the data obtained in a test study on the acute 
responses to hypoxia of the left and right ventricles of the rat heart. 
In the introduction, which is subdivided into two parts, some of the most important 
tools for assessing the heart physiology are summarized. Further, features of the 
validation of a new model are cited, the isolated autologous blood-perfused rodent 
heart, which was crucial for the performance of the target study. Technical 
characteristics of this method, namely the autologous blood rodent heart perfusion, 
were described and discussed in this chapter. Animal handling, heart and blood 
harvesting and initiation of the perfusion system as well as the necessary 
troubleshooting are also described here.  
Section 5 describes the assessment of the local changes in tissue ion content, redox 
state and glucose metabolism in response to acute hypoxia. The data obtained from 
the hearts harvested from rats exposed to systemic normobaric hypoxia for one hour 
were compared to those obtained in the isolated rat hearts perfused with hypoxic 
autologous blood. Special attention was paid to the right-to-left ventricular 
heterogeneity in hypoxic responses in both experimental settings. The use of isolated 
autologous blood-perfused rodent hearts provided an opportunity to precisely control 
the amount of oxygen delivered to the organ and to distinguish between the systemic 
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and autonomous responses of the heart to hypoxia. The findings of that study are 
summarized in section 6. These include the assessment of interventricular 
heterogeneity in the glucose utilization rate in normoxic and hypoxic hearts, as well 
as the capability for maintaining tissue ATP levels and redox state under conditions 
of reduced oxygen supply. The interventricular Na+ gradients that were maintained in 
the heart regardless of oxygen availability were monitored in both in vivo and ex vivo 
settings. These differences could be at least partially explained by the variations in 
the Na/K-ATPase activity between the right and the left ventricles. Taken together the 
observed differences in glucose metabolism, antioxidative defense systems and ion 
handling, these most likely reflect the interventricular differences in force generation. 
The present study revealed certain limitations of our model, one of which is a lack of 
loading. Data on redox state responses to hypoxia generated using an ex vivo model 
differed from those obtained in vivo. However, the changes in ion content and in 
glucose utilization rate correlated well between the in vivo and ex vivo models.  
The results obtained allowed us to follow the correlation between the local glucose 
utilization, the maintenance of ion gradients and the redox state. These observations 
indicate that anaerobic glycolysis is an essential element required to preserve the 
myocardial tissue from necrosis and sustain contractile function in hypoxic 
myocardium. Furthermore, we suggest that the RV is more susceptible to hypoxia-
induced damage than the LV.  
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4. Introduction 
Efficient prevention and treatment of cardiovascular diseases is based on the 
understanding of pathophysiological mechanisms underlying those disorders. 
Despite impressive results obtained for the therapeutic interventions using all 
available experimental models from in vivo animal studies in organ and cellular 
models, progress in the actual treatment of patients with cardiovascular diseases is 
modest (Mathers et al., 2009). Therefore, there is a long-standing demand for novel 
experimental tools and approaches to improve the outcome of cardiovascular 
research. Ideal experimental models must adequately reflect the clinical 
manifestation of pathology, as well be easy to handle and standardize. The current 
chapter introduces the variety of experimental models currently in use in 
cardiovascular research. Special attention is given to the Langendorff isolated 
perfused heart model.  
This section summarizes the results obtained during validation of the newly 
introduced blood-perfused heart model. These findings will be compared with the 
ones generated with the classical Langendorff model and the results of in vivo 
studies. The advantages and limitations of the newly developed model will be 
discussed. 
Exploration of the experimental potential of the model will be exemplified in the 
experiments which used the improved method to study effects of acute hypoxia in the 
denervated heart. These studies are summarized in chapter 5 and 6 of the thesis. 
 
4.0  Experimental models in cardiovascular clinical research 
At present, a broad array of experimental models from single molecules and 
molecular complexes to freshly isolated heart cells, isolated organs as well as small 
(rodents) and large animals models (Table 1) are used for the following purposes: a) 
characterisation of the molecular mechanisms of diseases; b) drug acute toxicity 
testing; c) development of new therapeutic strategies including i) optimisation of drug 
administration (acute and long-term studies), ii) drug turnover and metabolism, iii) 
optimization and development of new surgical procedures and iv) testing of the 
surgical equipment and consumables; and d) patient handling during and after the 
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invasive treatment phase. Each of these models has its own advantages and 
limitations which are summarised in Table 1 below. 
 
Table 1: Models and their applications 
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Molecular 
models 
+ - - - - - - 
Cells + ± - - - - - 
Strips + + ± ± ± - - 
ex vivo saline 
perfused heart 
+ + + ± ± ± - 
ex vivo blood 
perfused heart 
+ + + + + ± ± 
in vivo models + + + + + + ± 
 
 
 
 
 
 
4.1 Skinned fibres 
The heart ventricles are characterised by substantial electrical and mechanical 
heterogeneity (Markhasin et al., 2003). Therefore, an efficient heart function is 
dependent on the precise combination of electrical activation and myocardium 
activation (Markhasin et al., 2003). Several experiments which assess mechanical 
properties of the cardiac muscle are performed in skinned fibre. Chemical skinning 
results in intact contractile machinery and Ca2+ concentration can be precisely 
controlled through the use of Ca2+/EGTA buffers. Experiments based on 
measurement of Ca2+ tension transients followed by experiments in calcium step 
Legend:  
+ Suitable;  
± Difficulties in interpretation/poor clinical relevance;  
- Not suitable;  
 Incompatible with 3R principle (Remove, Reduce, Refine) 
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release and length step can be simplified in a mathematical model that considers (i) 
passive elasticity of cardiac tissue; (ii) Ca-binding to troponin C and its dependence 
on crossbridge tension; (iii) thin filament kinetics and associated length dependence; 
and (iv) crossbridge kinetics (Hunter et al., 1998). 
 
4.2 Cells 
Enzymatic digestion of the myocardial tissue has been developed to obtain adult or 
neonatal cardiomyocyte preparations. Among the main cell cultures used are i) 
neonatal cardiomyocytes (may be maintained in a culture for several days) (Webster 
& Patrick, 2000); ii) fresh-isolated adult cardiomyocyte (may be used during the first 
hours after isolation before the remodelling process is initiated) (Severs et al., 1989); 
and iii) cells lines such as HL-1 (Claycomb et al., 1998) and MCM1 (Sculptoreanu et 
al., 1992). 
Among the parameters assessed using isolated cardiomyocytes are 
electrophysiological recordings, Ca2+ handling, signalling mechanisms and role of the 
proteins of interest, as well as force development and function of the contractile 
machinery in paced cells. Among the experimental techniques requiring isolated 
cardiomyocytes are various forms of live imaging, patch clamping, force detection, 
western blot and immunohistochemistry as well as PCR, transfection and gene 
silencing. Lack of the intercellular contacts and cross-talk between different cell 
types, as well as loading and pressure distribution are among the limitations of this 
experimental model (Diaz & Wilson, 2006).  
 
4.3 Myocardial tissue strips 
Myocardial tissue strips can provide important information regarding the length-
dependent sensitivity of the contractile system to Ca2+. This type of preparation is a 
powerful tool for the investigation of effects of filament geometry on maximal force 
development and the effect of stretch of uniform muscle on sensitivity of the 
contractile system for Ca2+ ions (ter Keurs et al., 2008). This preparation is limited to 
mimicking the intact organ geometry (Klocke et al., 2007). 
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4.4 Ex vivo heart perfused models 
4.4.1 Isolated heart models 
The isolated retrograde perfused mammalian heart first described by Oscar 
Langendorff (Langendorff, 1898) is a simple method which allows the measurement 
of a broad spectrum of biochemical, physiological, morphological and pharmacologic 
indices in the mammalian myocardium (Sutherland & Hearse, 2000). Furthermore, 
the isolated organ is not subjected to sympathetic and vagal stimulation, enabling the 
monitoring of responses of the myocardium itself to the experimental stimuli. This 
low-cost and easy-to-manage model is often a major choice for the adjustment of 
doses of medicaments and the duration of treatments prior to the in vivo testing 
experiments. One of the main limitations of this method is the absence of blood or 
blood components in perfusion fluid, resulting in reduced oxygen supply to the 
myocardial tissue.  
 
4.4.2 Isolated perfused mammalian heart: a model of choice over 100 years 
Since its inception, the perfused mammalian heart preparation model has undergone 
some modifications but its basic principles remain unchanged (Fig 1). It allows 
simulation of low-flow to no-flow local or global ischemia, loss of rhythmicity and other 
pathologic conditions. The Langendorff model has been successfully used to study 
the molecular and cellular mechanisms underlying cardiovascular disorders, and for 
the development of acute therapeutic interventions and donor organ preservation 
strategies. (de Leiris et al., 1984; Curtis, 1998; Valentin et al., 2004; Skrzypiec-Spring 
et al., 2007)  
 
4.4.3 Perfusion fluids used in the Langendorff model 
The majority of scientists using the Langendorff heart perfusion system fill the 
perfusion circuit with the Krebs-Henseleit buffer containing: 25.0 mM NaHCO3 (2.1 
g/L), 118 mM NaCl (6.9 g/L), 4.7 mM KCl (0.35 g/L), 1.2 mM MgSO4 (anhydrous) 
(0.145 g/L), 1.2 mM NaH2PO4 (0.145 g/L), 1.2 mM CaCl2 (0.175 g/L), optionally 
containing 2 g/L glucose. The buffer is equilibrated with gaseous phase containing 
5% CO2, 95% O2 and warmed to 37°C. 
  
Figure 1: Blood-perfused myo
2000). 
This buffer was developed
However, it lacks plasma
acids. Its viscosity and the
substantially from that in 
al., 2007). Furthermore, d
capacity of Krebs-Hense
equilibration with 95% O
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Skrzypiec-Spring et al.
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donors” to be used in a single experiment will be unforgivably high (5 rats or 67 
mice). This increases experimental costs and does not comply with the 3R principle 
of animal experimentation.  
Using parabiotic preparations with a support animal (Fig 1) can reduce some of those 
complications. However, this model is almost as complex as in vivo models and does 
not allow precise control over the doses of applied drugs (they are often metabolized 
by the support animal). In addition, side and secondary effects of the support animal 
to the administrated drugs cannot be excluded or assessed reliably. It is difficult to 
control the blood oxygenation as it depends on the respiratory pattern of the support 
animal remaining under anaesthesia. Blood trauma will slowly occur over time as 
erythrocytes will be damaged when passing through the peristaltic pump, and the 
increase in plasma K+ will gradually impact heart function (Sutherland & Hearse, 
2000).  
Yet one more alternative approach is based on the development of haemoglobin-free 
blood substitutes whose oxygen carrying capacity exceeds that of the Krebs-
Henseleit buffer. Among those are perfluorochemical oxygen-carrying haemoglobin 
substitutes which are capable of transporting 5-10 ml O2/100 ml fluid (Lowe, 1999). 
Despite being efficient oxygen carriers, such O2 binding agents are unable to mediate 
O2 delivery and release of O2 in hypoxic tissues as effectively as intraerythrocytic 
haemoglobin (Table 2). 
 
Table 2: Oxygen carrying capacity and efficiency of oxygen delivery for different perfusion fluids 
 O2 carrying 
capacity (in 100ml 
fluid at 37°C) 
O2 delivery 
capacity 
Side effects 
Krebs-Henseleit 
buffer 
~0.4 ml O2 low None 
Haemoglobin-
free blood 
substitutes 
5-10 ml O2 low-medium Vasoconstriction 
Blood 20 ml O2 high None 
 
 
- 11 - 
 
4.5 In vivo models 
In vivo models are most reliable in reflecting the actual development of 
cardiovascular diseases. Rodents (mice and rats) and larger mammals (pigs and 
sheep) are extensively used for each of the above-mentioned model applications in 
Table 1. Existence of numerous transgenic mouse lines allows identification of the 
underlying mechanisms at the molecular level and selection of the potential drug 
targets. Rats are extensively used to investigate the causes and consequences of 
hypertrophy, myocardial infarction, cold global ischaemia-reperfusion and rejection 
(heterotrophic heart transplantation model). Large animal models are of primary 
interest for the surgeons as they allow the use of original equipment developed for 
human patients, imitating procedures used in cardiovascular surgery. Advanced as 
they are, these models possess a number of limitations as well. Larger animal 
models are expensive and complex. Positive results obtained using young and 
healthy animals to mimic the clinical situation often cannot be reproduced in clinics 
where the average age of patients is above 65-70 years. The negative outcome of 
the recent blinded randomized multicenter clinical trials testing cardioprotective 
efficacy of drugs which showed an impressive cardioprotective potential in large 
animal models was one of the recent disappointments revealing the limitations of 
large animal studies (Bolli et al., 2004). Therefore, more attention was recently paid 
to the improvement of isolated organ models enabling usage of the organs of aged 
and diseased rodents without causing unnecessary distress to the animals.  
 
4.6 Oxygenator and technical characteristics of the perfusion circuit  
A new miniaturized hollow fibre oxygenator (Fig 2) designed in our lab by Prof. J. 
Vogel in the Institute of Veterinary Physiology is a key element of the circulation 
circuit used for the perfusion of the rat heart with autologous blood. The total filling 
volume of this system is reduced from ≥100 ml, as common for the conventional 
Langendorff settings, to 5 ml. The same system was further miniaturized and 
adapted to a perfusion volume of ∼0.5 ml for the mouse heart perfusion setup. 
Funded by the 3R Research Foundation, my thesis focused on validation of the new 
perfusion setup and its capacity to Replace the animals used to assess basal 
cardiovascular toxicity of drugs as well as in pilot studies on responses of the heart to 
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severe hypoxia or ischemia/reperfusion, Reduce the number of tests performed in 
vivo, and Refine experimental conditions of these final tests.  
 
 
Figure 2: Schematic representation of the hollow fibre oxygenator and the perfusion circuit. 
 
 
 
 
 
 
 
4.6.1 Design of the hollow fibre mini oxygenator  
Mammalian lungs have a large interface area and high permeability to gases, 
allowing efficient gas exchange. The miniaturized oxygenator (Fig 2) was designed 
by Prof. Vogel as a part of a new rodent “heart-lung machine” prototype mediating 
O2/CO2 exchange with minimal damage to the circulating blood cells. Care was taken 
to avoid foaming or clot formation (Wegner, 1997). Structure and thickness of the 
fibres were selected to enable sufficient gas exchange within seconds (Iwahashi et 
al., 2004).  
The material which was used in construction of the mini oxygenators (Oxyphan® PP 
50/200 Membrane GmbH, maximal pore size ≤0.2 µm, wall thickness 50 µm, 
diameter 200 µm, length reduced to 12 cm) has been designed for the human heart-
CB 
Legend: 
A: Perfusion circuit scheme including the following components: (a) gas exchange chamber, (b) 
blood mixing chamber; (c): fibres permeable for gas and impermeable to water; (d) thermostat; 
(e) cannula with the heart mounted; (f) organ chamber equipped with an anti-clot filter (g) and  
ECG/heart rate electrodes (h); (i) PV tubing with holders; (j) peristaltic pump  
B: Frontal view on the oxygenator and the organ chamber  
C: Perfusion circuit with the peristaltic pump and the organ chamber with the mounted heart 
- 13 - 
 
lung machines (Fig 3). These fibres are permeable to gases but impermeable to 
liquids.  
In contrast to that for in vivo, in many oxygenators, blood was passing through the 
lumen of the fibre, whereas humidified gas was pumped through the gas exchange 
reservoir in contact with the external surface of the fibres (Fig 3). “Venous” blood 
passes though the in-coming bundle consisting of ~150 fibres for the rat setup (10 
fibres for the mouse setup), as shown in Fig. 2 (a), into the mixing chamber (b). 
Thereafter partially reoxygenated blood is forwarded through the exiting fibre bundle 
(c) into the heating chamber (d) and further into the cannula on which the heart is 
mounted (e). The perfusion chamber is equipped with circular electrodes to enable 
heart rate and ECG recordings during the perfusion. Temperature of the water 
jackets is adjusted so that the temperature in the exiting blood is maintained at 37°C. 
After passing through the coronary vessels, blood is collected in the water-jacketed 
organ chamber (f) and from there, pumped with a peristaltic pump (i) back into the 
oxygenator. Clots, if formed, are stopped from re-entering the perfusion circuit by a 
filter mesh (pore size 200 µm2 for the rat system and 10 µm2 for the mouse setup).  
The ECG comparable to aVL or II projections and the beat-to-beat calculated heart 
rate were recorded with a Heart Rate Modul (Hugo Sachs Elektronik) processed by a 
PowerLab analogue-digital transducer (AD Instruments) and stored as digital files for 
offline analysis.  
                
Figure 3: Human “artificial lung”. 
    
  
 
 
 
B  A  
Legend: 
A: Oxygenator scheme from www.meditronic.com. AFFINITY
®
 NT 
B: The original design 
a: Heat exchanger 
b: Gas exchange interface 
c: Perfusion fluid 
c 
b) 
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The left ventricular pressure in rat hearts was measured with hand-made catheter 
balloons (Fig 8) made of PVC film used for fresh food wrap and syringe needles 
attached via a polyethylene catheter (outer diameter: 0.96 mm) to a piezoelectric 
pressure transducer. The balloon was introduced into the left ventricular cavity via left 
atrium incision section. Then the balloon was gently inflated (~500 µl filling volume) to 
gain a pre-load of 1-5 mmHg. The pressure was continuously recorded using the 
PowerLab. 
The gas mixture used to saturate the circulating blood with oxygen contained 5% 
CO2, 20% O2 and 75% N2. The temperature was adjusted to 37°C and it was passed 
through the humidifier. The peristaltic pump (Dynamax, Ranin), in most cases, was 
adjusted to maintain a constant blood flow of 3 ml/min through the perfusion circuit 
mimicking in vivo rat heart coronary blood perfusion conditions. For the mouse 
perfusion setup, perfusion was adjusted to 0.8 ml/min.  
The blood volume necessary for one experiment was 5-8 ml for the rat and at least 
0.5 ml for the mouse perfusion circuit. In order to keep the perfusion system air-free 
and avoid thromboembolic events, the system was pre-filled with perfusion buffer of 
the following composition: 120 mM, NaCl: 25 mM, NaHCO3: 1 mM, CaCl2: 0.15 mM, 
MgCl2: 10 mM, glucose: 10 mM, TRIS-HCl (pH 7.4). Before heparinisation, blood was 
introduced in the system. As a result, the haematocrit of the final blood-buffer mixture 
ranged between 25% and 30%. 
 
4.6.2 Animal handling and tissue harvesting 
Rat: Male Wistar rats weighing 180-250 g (Elivage Javier) were used for the 
experiments. Animal keeping and experimentation were performed in accordance 
with Swiss animal protection laws and institutional guidelines. The rats were 
anesthetized using isofluorane (3% in a 1:1 mixture of O2 and N2O) and the 
abdominal cavity was opened. Heparin (~100 µl of 10’000 U/ml heparin, Brawn AG) 
was injected into the vena cava and thereafter 5-8 ml blood was collected. Rats were 
decapitated and the heart harvested was immediately placed in ice cold heparin-
containing perfusion buffer. 
Mouse: Approximately two-month-old C57BL6 mice (local breeding) were 
anesthetized using isofluorane, and the abdominal cavity was opened. Heparin (~100 
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µl) was injected into vena cava and thereafter, 1-2 ml blood was collected. Due to the 
increased risk of blood coagulation, mice received 100 µl of heparin subcutaneously 
30 minutes prior the experiment. The heart was harvested and immediately placed in 
the ice cold heparin-containing perfusion buffer. 
 
4.6.3 Heart mounting procedure and onset of perfusion 
Rat: After harvesting the heart, the aorta was isolated and the heart was mounted 
onto the cannula with the aorta sealed with suture (Fig 2). Care was taken to avoid 
thromboembolism and not to damage the aortic valve and the aortic walls. The time 
between harvesting and the onset of the perfusion never exceeded 5 minutes. At the 
time of mounting, the perfusion circuit was filled with oxygenated blood at room 
temperature. Perfusion was initiated at a rate of 3 ml/min, and the blood was 
gradually warmed to 37°C.  
Mouse: Excision and aortal isolation were performed under the binocular microscope. 
Mouse heart mounting required two pairs of hands. Perfusion with blood at room 
temperature was initiated at a flow rate of 0.8 ml/min and the temperature was 
gradually increased to 37°C. 
 
4.7 Validation of the model 
4.7.1 Blood properties in the perfusion circuit 
Blood gas content before and after introduction into the perfusion circuit was 
controlled using a blood gas analyser (phOx Nova plus, Nova Biomedical); the 
haematocrit was additionally assessed using microcapillaries, and haemolysis was 
measured with a Nanodrop 200 spectrophotometer (Thermo Scientific, Witec AG). 
Glucose levels in plasma were measured using a glucose meter and enzyme strips 
(Ascensia Elite Bayer). 
 
4.7.2  Water evaporation 
Rat: As mentioned above, blood haematocrit at the onset of the heart perfusion was 
somewhat lower than that in vivo: 30.69±11.72% vs. 24.25±16.22% in rats (mean 
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±SD, N=11). This dilution did not compromise O2 delivery to the myocardial tissue, 
but reduced blood trauma and clotting risks. Haematocrit values gradually increased 
with time due to gradual water evaporation from the organ chamber. This dehydration 
could be compensated by extra water supplementation aliquots at 40 µl/20 minutes. 
 
4.7.3 Plasma glucose depletion 
Rat: The glucose consumption by erythrocytes and myocardium resulted in a gradual 
deprivation of plasma glucose pools during perfusion. The glucose rate was 
assessed for the rat perfusion system (Fig 4). Based on the glucose consumption 
assessment, we have developed a protocol which avoids glucose deprivation along 
with water loss compensation. Glucose utilization by rat erythrocytes is found to be 
much higher than in hearts, 0.119±0.003 µmol/(gHb*min) (Hashimoto et al., 1996) 
and 0.03-0.05 µmol/(g*min) (Kuschinsky et al., 1993), respectively. Therefore, 
continuous glucose supply was necessary over time. Glucose consumption in rat 
blood in our system (0.60 µmol/gHb/min) was about five times higher than what has 
been reported in the literature. Glucose deprivation and loss of water from the 
perfusion circuit could be compensated by adding 40 µl aliquots of 140 mM glucose 
solution in water to the system every 20 minutes. The glucose and physiological 
solution were filtered through a 5 µm filter prior to use.  
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Figure 4: Rat plasma glucose levels with and without glucose adjustment. Aliquots (40 µl of 140 mM 
glucose stock solution) were added to the circulating blood each 20 minutes. 
 
Mouse: Plasma glucose levels were continuously monitored during perfusion and 2 µl 
of glucose solution (140 mM) was added whenever glucose levels declined. Glucose 
utilisation in this system was significantly lower compared to that in rat blood and in 
heart blood-perfused heart system. 
 
4.7.4 Haemolysis  
Special attention was given to the monitoring of blood trauma during the passage of 
erythrocytes through the perfusion system. Haemolysis was monitored in both rat 
and mouse blood over the course of perfusion (Fig 5) as haemoglobin and K+ release 
into plasma (Fig 5: A). Both factors may interfere with the heart function. 
Haemoglobin is a potent NO scavenger (Ascenzi & Visca, 2008) causing 
vasoconstriction, and free iron when liberated from haeme may cause oxidative 
stress in the endothelium by catalysing the Fenton reaction. An increase of plasma 
K+ results in depolarisation and may cause stunning when exceeding 7-8 mM. 
Without glucose adjustment 
With glucose adjustment 
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Figure 5: Blood trauma assessed in the rat and mouse perfusion circuits. 
 
 
 
 
 
Similar problems are well-described in clinical settings when human blood is 
processed by heart-lung machines. High shear stress, turbulence, and dilution of 
plasma causes haemolysis (Kameneva et al., 1999) (Watanabe et al., 2007) 
(Leverett et al., 1972; Paul et al., 2003). Moreover, contact of cells with non-biological 
surfaces facilitates thrombosis and cellular damage (Sutera, 1977). Among 
preventive measures undertaken to reduce haemolysis are the careful selection of 
the materials used in construction of the oxygenator and perfusion circuit as well as 
special construction of the peristaltic pumps to reduce blood trauma.  
Both free plasma haemoglobin and excessive K+ are removed from human blood 
passing through the heart-lung machine by introducing a filter. Plasma K+ is then 
supplemented to adjust the concentration to 3-4 mM. The extremely low volumes 
involved in our systems make this manipulation technically impossible. Thus, 
perfusion time in the rodent settings should be limited to 60-80 min. When necessary, 
longer perfusion times may require gradual replacement of blood used for perfusion. 
One adult rat may provide up to 15 ml blood from which 5-6 ml are required to prime 
the perfusion and fill the circuit. The rest may be stored for future use. 
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0
0.5
1
1.5
2
2.5
3
3.5
0 10 20 30 40 50 60 70
time, min
P
la
s
m
a
 h
e
m
o
g
lo
b
in
, 
g
/L
MouseRat 
B A 
Legend: 
A: Haemolysis in rat perfusion setup assessed as an increase in plasma K
+
 and extracellular 
haemoglobin accumulation.  
B: Haemolysis accessed in mice blood as plasma haemoglobin accumulation. 
 4.7.5 Efficiency of blo
The oxygenator blood-gas
cm2 for the mouse oxyge
capillary surface area (∼
2002). The following exp
efficiency of the mini oxyge
Based on the findings obta
to reach steady-state leve
set, rat blood was allowed
5% CO2, 25% O2 and 
decreased in intervals (20
mixture). The gaseous ph
fixed at 3 ml/min. Blood s
perfusion at a fixed pO2
The resulting rat haemogl
Fig 6 B. The SO50% obta
et al., 2006). The data ob
area, the hollow fibre oxyg
short period of time.  
 
 
Figure 6: Blood oxygenation in
 
 
 
Legend: 
A: Reoxygenation kinetics at 3
B: Haemoglobin oxygen satur
od oxygenation 
 interface areas (540 cm2 for the rat o
nator) were significantly smaller than 
5000 cm2 for a rat and ∼590 cm2 for a m
eriments were performed to assess t
nator. 
ined (Fig 6 A), two minutes were assess
ls of haemoglobin O2 saturation. In the 
 to pre-equilibrate with a humidified gas
70% N2. Thereafter, O2 levels in the 
%-15%-10%-5%-3%-1% down to a nom
ase always contained 5% CO2. The p
amples were collected at the end of the
 in the gaseous phase, and OxyHb leve
obin O2 saturation curve (SO50% of ~7
ined matches the values (~10% O2) repo
tained suggest that despite reduced b
enator efficiently performs gas exchange
 
 the hollow fibre oxygenator. 
 ml/min perfusion rate 
ation of rat blood as a function of pO2 in gas pha
A 
- 19 - 
xygenator and 36 
those of the lung 
ouse) (Soares S, 
he gas exchange 
ed to be sufficient 
next experimental 
 phase containing 
gas phase were 
inally O2-free gas 
erfusion rate was 
 second minute of 
ls were assessed. 
% O2) is shown in 
rted earlier (Julien 
lood gas interface 
 within a relatively 
 
se at 3 ml/min 
B 
- 20 - 
 
4.8 Heart function during long-term perfusion 
4.8.1 Heart rate 
The spontaneous heart rate assessed in an isolated blood perfused organ remained 
stable over an hour. As the temperature of the organ gradually increased from ~ 4°C 
to 37°C, the heart rate increased and stabilized at 37°C (Fig 7A). The spontaneous 
heart rate ranged between 200 and 380 beats/min which was lower than that 
reported in the conscious animal (400-480 beats/min) and similar to that in 
Langendorff preparations (250-320 beats/min) (Sutherland & Hearse, 2000) or in 
anesthetized animals (320-380 beats/min) (Hayashi, 2003). In some senescent 
animal hearts, arrhythmias and stunning were observed. However, deoxygenation 
often (up to 80%) resulted in development of arrhythmia. An example of stunning 
caused by hypoxic treatment in the senescent heart is shown in Fig 7 B. 
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Table 3: Rat ECG paramete
Parameter 
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were wet-burned with ultra-pure concentrated HNO3. Tissue Na
+ and K+ content were 
then determined using flame photometry (IL- 943, Instrumentation Laboratory, 
Bedford, MA, USA). The results obtained were normalized to the dry weight of the 
sample. 
The tissue GSH, GSSG and ATP levels were assessed in blood-free ventricular 
tissue preparations. Frozen ventricular fragments (~0.1 g) were homogenized on ice 
in KCl-MOPS buffer (100 mM KCl and 10 mM MOPS, pH 7.4 and deproteinized with 
5% trichloroacetic acid). After centrifugation (5 min, 9000·g, at 4°C), an aliquot of the 
protein-free supernatant was neutralized to pH~7 with TRIS-OH powder, and ATP 
was assessed using an ATP Bioluminescent Assay Kit (FLAA, Sigma, St Louis, MO, 
USA). The luminescence intensity in the heart tissue samples and in standard the 
samples of known ATP content was monitored using a Sirius luminometer (Berthold 
Detection Systems). Values were normalized to tissue wet weight. GSH and GSSG 
were assessed in the protein-free supernatant using Ellmann’s reagent and also 
normalized to sample wet weight. 
Hydrolytic activity of the Na,K-ATPase was determined in ventricular tissue 
homogenates from the isolated blood-perfused hearts exposed to normoxia or 
hypoxia (20 or 5% O2 in gas phase) for 60 minutes. Na,K-ATPase hydrolytic activity
 
was assayed as previously described (Rathbun & Betlach, 1969). In brief, ventricular 
tissue was homogenized in KCl-MOPS buffer and an aliquot was added to the 
medium containing 130 mM NaCl, 20 mM KCl, 3 mM MgCl2 and 1 mM ouabain when 
mentioned (37°C, 10 min). In the presence of these saturating concentrations of the 
Na,K-ATPase substrate and ligands, the measured enzymatic activity corresponds 
the pseudo-maximal ATP cleavage rate, pseudo Vmax. Na,K-ATPase hydrolytic 
function was assessed as the difference in ATP cleavage rate in the presence and 
absence of 1 mM of blocker, ouabain. The enzymatic ATP hydrolysis was initiated by 
adding ATP-HEPES-NaOH mixture (final concentrations in the medium were 3 mM 
and 30 mM, respectively) and allowed to proceed for 7 minutes, after which it was 
stopped by adding the ice-cold stopping solution (4% formaldehyde in 1.3 M sodium 
acetate buffered with acetic acid to pH 4.3). The samples were mixed with 100 µl of 
SnCl2
 solution (15 mg SnCl2 in 5 ml of 0.002% acetic acid) and 100 µl
 of 2% 
(NH4)2MoO4 solution in distilled water. After 15 min, a coloured
 complex of phosphate 
with Sn2+ and (MoO4)
2- was formed and was evaluated by measuring the optical 
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density (660 nm, Lambda 25 spectrophotometer, Perkin Elmer). Blank samples 
contained no cell lysates or the lysates were added after the ATP hydrolysis was 
stopped. The hydrolytic activity of Na/K ATPase was calculated as a difference in the 
rate of phosphate production in the corresponding ouabain-free and ouabain-
containing sample pairs. Activities were normalized to the amount of protein in the 
homogenates, and quantified using the Bio-Rad protein assay (Bio-Rad Laboratories 
Inc., USA).  
 
4.9.2 Metabolism and tissue ATP levels 
The ATP demands of the isolated unloaded heart were lower than those observed in 
vivo. As a result, ATP levels measured in the myocardium ex vivo exceeded those 
obtained in freshly isolated myocardium (5.2±1.1 vs. 3.01±0.63 µmol/g wet weight 
respectively, p<0.05). The values obtained for the glucose utilization rate in the 
isolated heart (20.23±4.47 µmol/(100g*min)) measured by means of 14C-DOG 
autoradiography were slightly lower than those in vivo (30-50 µmol/(100g*min)) 
obtained with the same technique (Kuschinsky et al., 1993). 
 
4.9.3 Water and ions 
Ta data presented in Table 4 reveal the changes in biochemical parameters of the 
myocardial tissue that could follow 90 minutes of rat heart perfusion with well-
oxygenated autologous blood compared to those in a fresh-isolated organ. 
Biochemical parameters listed in Table 4 were assessed in isolated blood-perfused 
rats. Among those parameters are reduced (GSH) and oxidized (GSSG) glutathione, 
and ATP levels. The Na+ and K+ content were measured in ventricular tissue as 
described.  
The ex vivo perfusion did not affect the ion and water content of ventricular tissue. 
However, it resulted in the development of oxidative stress which is due to a 
reduction in GSH and accumulation of GSSG. 
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Table 4: Water and ion measurements in rat hearts 
Parameter ex vivo in vivo 
 Water (%) 72.51 ±0.72 74.1 ±0.2 
 Na+(mmol/Kg dw) 43.28 ±16.29  49.2 ±2.6 
 K+(mmol/Kg dw) 269.44 ±21.32  285.0 ±7.1 
 GSH (µmol/g ww) 1.51 ±0.36 2.223 ±0.059 
 GSSG (µmol/g ww) 0.104 ±0.039 0.44 ±0.21* 
* p < 0.05 
 
4.9.4 Redox state 
Excessive amounts of oxygen in blood saturated with 21% O2-containing gas mixture 
caused tendency to moderate oxidative stress in the myocardium.  
 
4.10 Our model of choice 
The autologous blood-perfused rodent heart model is a promising technique in the 
field of cardiovascular research and it was of crucial importance to our study. It 
closely mimics the in vivo conditions without promoting animal suffering, and 
therefore adheres to the 3R’s principle. This model fills the niche between the cellular 
and in vivo levels of complexity (Table 1). 
The validation of the model demonstrated that the function of the isolated blood-
perfused heart (HR, LVP and ECG as well as the ion/water balance) and some of the 
basic biochemical parameters in myocardial tissue remained stable for at least 90 
minutes of perfusion and did not deviate significantly from the in vivo values. The 
oxygenation of the organ is sufficient to support its autonomous function. This model 
may be further used to assess the effects of drugs and treatments under controlled 
standardized conditions (perfusion rate, drug concentrations, temperature regiment). 
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Particularly in this study, the use of this method allowed us to further increase 
hypoxic stress in rat hearts under conditions that wouldn’t be possible in in vivo 
experiments. Furthermore, this was a precious tool, which permitted us to better 
understand acute cardiac stress in the absence of sympathetic and cholinergic 
effects.  
- 28 - 
 
5. Model application: Myocardial responses to hypoxia 
5.0  Motivation and goals 
We used the isolated blood perfused heart model to monitor autonomous heart 
responses to hypoxia. Metabolic enzymes (Lopaschuk et al., 2010), cation channels 
(Hool, 2005), redox state (Park et al., 2007) and calcium handling (Pravdic et al., 
2009) in the heart are known to respond rapidly to the changes in the myocardial 
oxygen supply. Oxygen consumption in the heart exceeds that of the brain (Dobson, 
2004). Having a mass of about 0.4% of the total mass of the human body, the heart 
is responsible for around 16% of total oxygen consumption. Reduction in oxygen 
supply leads to a reduction in cardiac output (Calbet et al., 2009) and arrhythmias 
(Keating & Sanguinetti, 2001) which in turn are the cause of a high number of deaths 
and hospitalisations (Madsen et al., 2007). 
 
5.1. Objectives 
Objectives of the study performed using the new experimental system were: 
1. Characterization of the isolated rat heart responses to acute global hypoxia 
and comparison of the observed findings with those obtained for the 
systemic in vivo hypoxic model.  
2. Assessment of the possible interventricular variation in hypoxic responses. 
 
Among the parameters monitored were functional parameters (heart rate and ECG), 
biochemical parameters (glucose utilization rate (Kuschinsky et al., 1993), tissue ATP 
(Petrushanko et al., 2006), Na+/K+ and water content (Tanonaka et al., 1999) and the 
hydrolytic activity of Na,K ATPase (Rathbun & Betlach, 1969; Bogdanova et al., 
2005), as well as the tissue redox state (reduced to oxidized glutathione ratio and 
half-cell redox potential Ehc for this redox couple. (Ehc = -240 – 
(59.55/2)log(GSH)2/[GSSG])) (Tietze, 1969) (Schafer & Buettner, 2001). Tissue 
biochemical parameters were assessed in the right (RV) and the left (LV) ventricle 
separately.  
In vivo hypoxic exposure was performed in the InVIVO 1000® hypoxic cabinet. The 
animals (male Wistar rats 180-250 g) were exposed to 10% oxygen for 1 hour, 
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sacrificed and the heart collected. Ex vivo hypoxia was performed using the heart 
and blood of sex and age-matched animals. Isolated hearts were perfused with 
autologous blood equilibrated with a gas phase containing either 21% (normoxia) or 
5% (hypoxia) O2 at 37°C for 1 hour. Heart rate and ECG (aVL projection) in isolated 
perfused hearts were recorded with a Heart Rate Modul (Hugo Sachs Elektronik) 
attached to the PowerLab analogue digital transducer (PowerLab AD Instruments). 
Data were stored as numeric files and analyzed manually using Microsoft-Excel 
software. 
The data obtained were summarized in a paper recently published in the American 
Journal of Physiology (see following chapter). 
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6. Manuscripts 
6.1. Manuscript  
Interventricular heterogeneity in rat heart responses to hypoxia: the tuning of glucose 
metabolism, ion gradients, and function  
Published at: American Journal of Physiology, 2011 
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6.2. 3R Bulletin  
 Refined ex vivo heart model reduces in vivo experimentation 
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7. Outlook 
The present work was performed to characterise a new experimental model and to 
show its potential in several test studies. The comparison of the basic functional and 
biochemical parameters indicated that the model fills the niche between the 
conventional ex vivo and in vivo rodent models helping to reduce the number of 
animals normally used for in vivo testing. The lack of loading is a drawback of the 
model which must be kept in mind (see Section 5). Blood trauma and gradual 
accumulation of K+ in the plasma must also be considered.  
Among the potential applications of the model are: 
• Drug toxicity testing 
• Ischemia-reperfusion injury 
• Acute adaptive responses (preconditioning) 
• Functional tests in transgenic animals 
• Vascular permeability measurements  
• Assessment of action of enzyme inhibitors/activators of autonomous heart 
function. 
Using our isolated blood-perfused heart model, we have monitored interventricular 
heterogeneity in the glucose utilization rate, as well as in maintenance of ATP levels, 
GSH:GSSG ratio and tissue Na/K content under normoxic and hypoxic conditions.  
The results of these studies allowed us to follow the correlation between local 
glucose utilization, maintenance of ion gradients and the redox state. These 
observations indicate that anaerobic glycolysis is an essential element required to 
preserve the myocardial tissue from necrosis and sustain contractile function in 
hypoxic myocardium. Furthermore, our data suggest that the RV is more susceptible 
to the hypoxia induced damage than the LV.  
These interesting findings remain largely phenomenological and further studies are 
required to elucidate the molecular mechanisms of the observed responses. In order 
to better understand the cause of this heterogeneity and to establish the possible 
links between glucose metabolism, the control over the tissue redox state and the 
function of sarcolemmal Na, K-ATPase, the following questions have to be answered: 
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• What are the mechanisms involved in the control of local glucose uptake in the 
ventricles?  
• What are the factors that allow maintenance of NADH and NADPH levels and 
thereby the GSH:GSSG ratio in the hypoxic LV?  
• Is there any interaction between the redox state and glucose uptake in the LV 
which is lacking/suppressed in the RV? 
We suggest that the rapid increase in glucose utilization in the ex vivo left ventricle 
exposed to hypoxia is mediated by recruitment of internalized Glut-4 glucose 
transporters to the sarcolemma. Further experiments are required to confirm this 
hypothesis and to search for the possible mechanisms in control of glucose 
utilization/redox state regulation with investigation of the redox and oxygen sensitivity 
of Glut-4 internalization/ externalization.  
Glucose utilization in the hypoxic apex shared the same pattern with that in the RV. 
This observation leads to the question of developmental aspects of hypoxic 
responses in the heart. As mentioned in our article, apex and LV cells have the same 
embryonic precursor which is different from that of tissue forming the RV. How did 
these site specific responses evolve and at what stage of evolution do they appear? 
The comparison of local hypoxic responses of ventricular tissue in vertebrates 
possessing two, three and four chambers (in both hypoxia-tolerant and hypoxia-
sensitive species) of the heart might help to answer this question.  
One more question that remains open is whether the changes in glucose utilization 
rate in the rat heart ventricles in response to deoxygenation in our ex vivo model 
reflect those occurring in vivo. As a part of the validation procedure, in vivo 
measurements of the changes in glucose utilization (18F-deoxyglucose used as a 
marker) in the hearts of anesthetized rats breathing hypoxic gas mixtures are 
currently being performed using positron emission tomography. The data obtained 
will then be compared with the results generated using autoradiography (14C-
deoxyglucose) in isolated blood-perfused rat heart. More studies using this model are 
currently ongoing in our lab. An example of the model application is described below. 
 
To test if our model may be used to mimic clinical settings and assist in the 
development of therapeutic strategies, we further plan to use the isolated blood-
perfused heart model to mimic ischemia-reperfusion injury in the heart. To do so, the 
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heart will be arrested, submitted to global cold ischemia and then perfused with 
autologous blood saturated with oxygen. The data obtained will be then compared 
with that generated using the in vivo heterotrophic rat heart transplantation model. In 
both models, the ischemic heart remains unloaded at the onset of reperfusion. This 
study will allow distinguish between the autonomous response of the myocardium to 
ischemia-reperfusion and that caused by humoral factors and inflammatory cytokines 
released into the circulation in response to stress in the in vivo settings. We plan to 
start by using the isolated blood-perfused heart model for investigation of the 
cardioprotective effect of human recombinant erythropoietin (Epo) which was 
previously shown to reduce ischemia-reperfusion injury in heterotopically 
transplanted rat hearts (Mihov et al., 2009). In particular, we would like to extend our 
search for the mechanisms of Epo-induced cardioprotection to the effect of this 
haematopoietic cytokine on the efficiency of capillary perfusion in the post-ischemic 
myocardium. Evance blue dye shall be used to visualize capillary filling 
microscopically as it has been done previously to evaluate brain capillary perfusion 
(Vogel et al., 1997). These are the plans for the immediate future after publishing the 
thesis. The author is convinced that the results obtained will attract the attention of 
colleagues in the field of heart and circulatory physiology to the new model. 
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